Altered CD3 chain and cytokine gene expression in tumor infiltrating T lymphocytes during the development of mesothelioma
- 15 May 1996
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 103 (1) , 1-9
- https://doi.org/10.1016/0304-3835(96)04178-x
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Potential for Interferon-α-Based Therapy in Mesothelioma: Assessment in a Murine ModelJournal of Interferon & Cytokine Research, 1995
- The decreased expression of CD3 ζ chains in cancer patients is not reversed BY IL‐2 AdministrationInternational Journal of Cancer, 1994
- Heterogeneity of single cell cytokine gene expression in clonal T cell populations.The Journal of Experimental Medicine, 1994
- Induction of CD3δɛω) by phorbol 12-myristate 13-acetateEuropean Journal of Immunology, 1993
- Differential effect of transforming growth factor β on the synthesis of Th1‐ and Th2‐like lymphokines by human T lymphocytesEuropean Journal of Immunology, 1992
- Early signaling defects in human T cells anergized by T cell presentation of autoantigen.The Journal of Experimental Medicine, 1992
- Quantitative analysis of lymphokine expression in vivo and in vitroImmunology & Cell Biology, 1992
- Properties of recombinant interleukin 2-cultured tumor-infiltrating lymphocytes in human lung cancerInternational Journal of Cancer, 1989
- The T Cell Receptor/CD3 Complex: A Dynamic Protein EnsembleAnnual Review of Immunology, 1988
- Tolerance of T-cell clones is associated with membrane antigen changesNature, 1983